Shilajit and bones & joints

What 2 graded rows on shilajit agree on for bones & joints, and where they differ. Counted side by side, never averaged.

What the rows agree on

Each block and row is one graded row from the Shilajit page, with its PubMed record.

Your question

Supplement

Shilajit and bones & joints

2 rows · 95 people

They agree: both rows found an improvement.

No difference
Improved
Each block is one evidence row, sized by how many people it enrolled, with its grade inside.
  • Grade D× 2
Rows
2
Trials
2
People
95

What the rows share

From the rows

The best-graded row, grade D, is a randomized trial of 60 people (2022) and found an improvement.

The rows run from 35 to 60 people, published from 2022 to 2024: 2 single studies.

The rows

2 improved
  1. Grade DBone mineral density after menopause · Improved

    RCT · n 60 · 2022 · Postmenopausal women aged 45–65 with osteopenia

    250 or 500 mg/day · 48 weeks

    Spine and hip bone density fell with placebo but was dose-dependently preserved with shilajit; bone-turnover, oxidative-stress and CRP markers improved.

    Row on the Shilajit page · PubMed 35933897 (opens PubMed)

  2. Grade DType 1 collagen synthesis marker · Improved

    RCT · n 35 · 2024 · Recreationally trained men

    500 or 1,000 mg/day · 8 weeks

    Serum pro-c1α1 roughly doubled in both shilajit groups and did not change with placebo.

    Row on the Shilajit page · PubMed 36546868 (opens PubMed)

Educational only. Not medical advice. Some links earn us a commission: kymatahealth.com/affiliate-disclosure.